798 related articles for article (PubMed ID: 17658994)
21. The genetics of generalized vitiligo and associated autoimmune diseases.
Spritz RA
J Dermatol Sci; 2006 Jan; 41(1):3-10. PubMed ID: 16289692
[TBL] [Abstract][Full Text] [Related]
22. Evidence for an autoimmune pathogenesis of vitiligo.
Ongenae K; Van Geel N; Naeyaert JM
Pigment Cell Res; 2003 Apr; 16(2):90-100. PubMed ID: 12622785
[TBL] [Abstract][Full Text] [Related]
23. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells.
Cui J; Bystryn JC
Arch Dermatol; 1995 Mar; 131(3):314-8. PubMed ID: 7887661
[TBL] [Abstract][Full Text] [Related]
24. Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo.
Le Gal FA; Avril MF; Bosq J; Lefebvre P; Deschemin JC; Andrieu M; Dore MX; Guillet JG
J Invest Dermatol; 2001 Dec; 117(6):1464-70. PubMed ID: 11886510
[TBL] [Abstract][Full Text] [Related]
25. The genetics of generalized vitiligo.
Spritz RA
Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
[TBL] [Abstract][Full Text] [Related]
26. Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo.
Steitz J; Wenzel J; Gaffal E; Tüting T
Eur J Cell Biol; 2004 Dec; 83(11-12):797-803. PubMed ID: 15679123
[TBL] [Abstract][Full Text] [Related]
27. [Symptomatic tapetoretinal degeneration in pigment disorders of the skin: approaches to understanding the pathomechanism and therapy].
Krastel H; Anton-Lamprecht I; Alexandridis E; Tilgen W
Fortschr Ophthalmol; 1985; 82(6):562-70. PubMed ID: 4093108
[No Abstract] [Full Text] [Related]
28. Vitiligo: interplay between oxidative stress and immune system.
Laddha NC; Dwivedi M; Mansuri MS; Gani AR; Ansarullah M; Ramachandran AV; Dalai S; Begum R
Exp Dermatol; 2013 Apr; 22(4):245-50. PubMed ID: 23425123
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune etiology of generalized vitiligo.
Le Poole IC; Luiten RM
Curr Dir Autoimmun; 2008; 10():227-43. PubMed ID: 18460889
[TBL] [Abstract][Full Text] [Related]
30. Vitiligo following type II lepra reaction.
Pavithran K
Indian J Lepr; 1989 Jan; 61(1):44-8. PubMed ID: 2703744
[TBL] [Abstract][Full Text] [Related]
31. Why tyrosinase for treatment of melanoma.
Song YH
Lancet; 1997 Jul; 350(9071):82-3. PubMed ID: 9228956
[No Abstract] [Full Text] [Related]
32. Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity.
Ramirez-Montagut T; Turk MJ; Wolchok JD; Guevara-Patino JA; Houghton AN
Oncogene; 2003 May; 22(20):3180-7. PubMed ID: 12789294
[TBL] [Abstract][Full Text] [Related]
33. [Characterization of antigens reacting with vitiligo and cytoplasmic melanoma antibodies].
Presser HJ; Morenz J; Höfs T; Zugehör M; Kühne KH; Brödemann M
Dermatol Monatsschr; 1987; 173(8):441-5. PubMed ID: 3311840
[No Abstract] [Full Text] [Related]
34. A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.
Jadeja SD; Mayatra JM; Vaishnav J; Shukla N; Begum R
Front Immunol; 2020; 11():624566. PubMed ID: 33613564
[TBL] [Abstract][Full Text] [Related]
35. New insights into immune mechanisms of vitiligo.
Boniface K; Taïeb A; Seneschal J
G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
[TBL] [Abstract][Full Text] [Related]
36. [Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?].
Marcet B; Sibaud V; Géniaux M; Taieb A
Ann Med Interne (Paris); 2002 Sep; 153(5):349-50. PubMed ID: 12442082
[TBL] [Abstract][Full Text] [Related]
37. Use of anti-tumor necrosis factor agents: a possible therapy for vitiligo.
Lv Y; Li Q; Wang L; Gao T
Med Hypotheses; 2009 May; 72(5):546-7. PubMed ID: 19201101
[TBL] [Abstract][Full Text] [Related]
38. [Association of lupus erythematosus and vitiligo (author's transl)].
Forestier JY; Ortonne JP; Thivolet J; Souteyrand P
Ann Dermatol Venereol; 1981; 108(1):33-8. PubMed ID: 7235502
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis of melanocytes in vitiligo results from antibody penetration.
Ruiz-Argüelles A; Brito GJ; Reyes-Izquierdo P; Pérez-Romano B; Sánchez-Sosa S
J Autoimmun; 2007 Dec; 29(4):281-6. PubMed ID: 17888626
[TBL] [Abstract][Full Text] [Related]
40. [Vitiligo].
Njoo MD; Westerhof W
Ned Tijdschr Geneeskd; 1997 Apr; 141(16):759-64. PubMed ID: 9213796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
